Interestingly, these mechanisms parallel findings in a mouse model of the learning disabilities associated with neurofibromatosis type I (NF1), where Nf1 heterozygous null mutants exhibit enhanced ERK signaling and increased GABA release in the hippocampus. The gene discussed is MAPK1; the disease is neurofibromatosis type 1.